Repligen | RGEN - Операционный доход

Биржевая цена
113.88
Изменение за день
-3.73 -3.17%
Ежемесячно
-15.89%
Ежегодный
-18.67%
Q1 прогноз
110.46




Операционный доход Изменить Дата
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
General Electric Aerospace USD 1.77B 536M 2025-12
Henry Schein USD 186M 12M 2025-12
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12
West Pharmaceutical Services USD 162.5M 5.1M 2025-12